In addition, Chen et al. have shown that the overexpression of the microRNA miR-133b increased ovarian cancer cell sensitivity to both cisplatin and paclitaxel by decreasing glutathione GSTP and multidrug resistance protein 1 (MDR1) expression [56]. The gene discussed is ABCB1; the disease is ovarian cancer.